Status:
UNKNOWN
Serum DNA Analysis: Potential Application for Diagnosis and Prognosis in Brain Cancer.
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Primary Brain Tumor
Eligibility:
All Genders
Brief Summary
Numerous studies document the ability of tumors to shed DNA into the blood stream. Circulating DNA can thus be recovered for analyses, representing a surrogate tumor material to test for potential app...
Detailed Description
Backround: Genetic and epigenetic abrasions like loss of hetherozygosity and hypermethylation of gene promoters are common aberration in gliomas. Detection of these aberrations serves as diagnostic a...
Eligibility Criteria
Inclusion
- LOW AND HIGH GRADE GLIOMAS
Exclusion
- NON GLIAL TUMORS
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00265174
Start Date
January 1 2006
Last Update
December 14 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hdassah Medical Organization
Jerusalem, Israel, 91120